Literature DB >> 31384060

Synaptic vesicle fusion: today and beyond.

Nils Brose1, Axel Brunger2, David Cafiso3, Edwin R Chapman4, Jiajie Diao5, Frederick M Hughson6, Meyer B Jackson4, Reinhard Jahn7, Manfred Lindau8, Cong Ma9, Josep Rizo10, Yeon-Kyun Shin11, Thomas H Söllner12, Lukas Tamm3, Tae-Young Yoon13, Yongli Zhang14.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31384060     DOI： 10.1038/s41594-019-0277-z

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN： 1545-9985            Impact factor:   15.369


× No keyword cloud information.
  5 in total

1.  Molecular Basis for Synaptotagmin-1-Associated Neurodevelopmental Disorder.

Authors:  Mazdak M Bradberry; Nicholas A Courtney; Matthew J Dominguez; Sydney M Lofquist; Andrew T Knox; R Bryan Sutton; Edwin R Chapman
Journal:  Neuron       Date:  2020-05-01       Impact factor: 17.173

2.  Role of Munc18-1 in the biological functions and pathogenesis of neurological disorders (Review).

Authors:  Fajuan Tang; Dongqiong Xiao; Lin Chen; Hu Gao; Xihong Li
Journal:  Mol Med Rep       Date:  2021-01-26       Impact factor: 2.952

Review 3.  In vitro single vesicle fusion assays based on pore-spanning membranes: merits and drawbacks.

Authors:  Peter Mühlenbrock; Merve Sari; Claudia Steinem
Journal:  Eur Biophys J       Date:  2020-12-15       Impact factor: 1.733

4.  Resolving the molecular architecture of the photoreceptor active zone with 3D-MINFLUX.

Authors:  Chad P Grabner; Isabelle Jansen; Jakob Neef; Tobias Weihs; Roman Schmidt; Dietmar Riedel; Christian A Wurm; Tobias Moser
Journal:  Sci Adv       Date:  2022-07-15       Impact factor: 14.957

5.  Ultrastructural Imaging of Activity-Dependent Synaptic Membrane-Trafficking Events in Cultured Brain Slices.

Authors:  Cordelia Imig; Francisco José López-Murcia; Lydia Maus; Inés Hojas García-Plaza; Lena Sünke Mortensen; Manuela Schwark; Valentin Schwarze; Julie Angibaud; U Valentin Nägerl; Holger Taschenberger; Nils Brose; Benjamin H Cooper
Journal:  Neuron       Date:  2020-09-28       Impact factor: 17.173
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.